Clinical Trial

Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes

Study acronym: CAAD-PVC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Premature ventricular complexes (PVCs) are extra, abnormal heart beats arising from the ventricles of the heart and are the most common ventricular arrhythmia. PVCs can be treated with medication or with a procedure called catheter ablation. It is not known which provides a better cure or provides better quality of life. The purpose of this research project is to study the best way to treat PVCs by comparing the use of medication to catheter ablation to assess which approach is better at reducing symptoms and improving quality of life.
Trial Details
NCT Number NCT07445334
Lead Sponsor Western Sydney Local Health District
Conditions Premature Ventricular Complexes, Premature Ventricular Contraction (PVC), Premature Ventricular Beats
Enrollment 40 participants
Start Date 2026-03-01
Primary Completion 2027-09-01 (estimated)
Study Completion 2028-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-03